NO20084187L - Medikamenter og proteiner - Google Patents

Medikamenter og proteiner

Info

Publication number
NO20084187L
NO20084187L NO20084187A NO20084187A NO20084187L NO 20084187 L NO20084187 L NO 20084187L NO 20084187 A NO20084187 A NO 20084187A NO 20084187 A NO20084187 A NO 20084187A NO 20084187 L NO20084187 L NO 20084187L
Authority
NO
Norway
Prior art keywords
drugs
medications
proteins
fragments
derivatives
Prior art date
Application number
NO20084187A
Other languages
English (en)
Norwegian (no)
Inventor
Mark William James Ferguson
Hugh Gerard Laverty
Nick Occleston
Sharon O'kane
Emma Atkinson
Phillip Mellors
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of NO20084187L publication Critical patent/NO20084187L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20084187A 2006-03-11 2008-10-07 Medikamenter og proteiner NO20084187L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0604966.2A GB0604966D0 (en) 2006-03-11 2006-03-11 Medicaments and proteins
PCT/GB2007/000834 WO2007104946A2 (fr) 2006-03-11 2007-03-12 Médicaments et protéines

Publications (1)

Publication Number Publication Date
NO20084187L true NO20084187L (no) 2008-10-07

Family

ID=36241467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084187A NO20084187L (no) 2006-03-11 2008-10-07 Medikamenter og proteiner

Country Status (13)

Country Link
US (1) US7902150B2 (fr)
EP (2) EP2012812A2 (fr)
JP (1) JP2009543757A (fr)
KR (1) KR20080100828A (fr)
CN (1) CN101605555A (fr)
AR (1) AR062773A1 (fr)
BR (1) BRPI0708791A2 (fr)
GB (1) GB0604966D0 (fr)
IL (1) IL193700A0 (fr)
MX (1) MX2008011707A (fr)
NO (1) NO20084187L (fr)
RU (1) RU2008140117A (fr)
WO (1) WO2007104946A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009221164A (ja) * 2008-03-17 2009-10-01 Nitto Denko Corp 肺線維症処置剤
EP4005601A1 (fr) 2004-12-22 2022-06-01 Nitto Denko Corporation Vecteur médicamenteux et kit de vecteur médicamenteux permettant d'inhiber la fibrose
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0724204D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for inhibition of scarring
GB0724203D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for the inhibition of scarring
BR112013019803A2 (pt) * 2011-02-02 2019-06-11 Excaliard Pharmaceuticals Inc método de tratar quelóides ou cicatrizes hipertróficas usando os compostos anti-sentido objetivando fator de desenvolvimento de tecido conjuntivo (ctgf)
JP7531887B2 (ja) 2020-07-31 2024-08-13 学校法人関西医科大学 ＴＧＦ－βを含む組織の線維化抑制剤
WO2023069629A1 (fr) * 2021-10-20 2023-04-27 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Méthodes de traitement d'une maladie intestinale inflammatoire
WO2023206188A1 (fr) * 2022-04-28 2023-11-02 Wenzhou Prarucom Bio-Chemical Technology Co. Méthode pour soulager la fibrose pulmonaire à l'aide d'un facteur de croissance épidermique

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051848A (en) * 1976-03-01 1977-10-04 Levine Norman S Synthetic skin wound dressing
IL78197A (en) 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
US6559123B1 (en) * 1985-04-19 2003-05-06 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
US5135915A (en) * 1988-10-14 1992-08-04 Genentech, Inc. Method for the treatment of grafts prior to transplantation using TGF-.beta.
AU6870791A (en) 1989-10-18 1991-05-16 Creative Biomolecules, Inc. Biosynthetic constructs of tgf-beta
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
AU3943793A (en) * 1992-04-01 1993-11-08 Whittier Institute For Diabetes And Endocrinology, The Methods of inhibiting or enhancing scar formation in the CNS
US5411940A (en) * 1993-09-29 1995-05-02 Alcon Laboratories, Inc. Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma
US5399677A (en) 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
TW440566B (en) 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein
TW517059B (en) * 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
PT840748E (pt) 1995-07-25 2003-08-29 Novartis Ag Cristais de factor de crescimento transformante beta
DE69636739T2 (de) 1995-12-21 2007-10-18 Ajinomoto Co., Inc. Verfahren zur rückfaltung von menschlichem activin a
WO1997041899A1 (fr) * 1996-05-03 1997-11-13 Innogenetics N.V. Nouveaux medicaments contenant de la gelatine reticulee avec des polysaccharides oxydes
EP1074620A1 (fr) * 1999-08-06 2001-02-07 HyGene AG Protéine monomère de la famille TGF-beta
JPH11335398A (ja) * 1998-05-22 1999-12-07 Hoechst Marion Roussel Kk 新規な骨誘導活性を有する単量体蛋白質およびそれらからなる軟骨・骨疾患の予防および治療薬
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
WO2000001410A1 (fr) * 1998-07-06 2000-01-13 Beth Israel Deaconess Medical Center Procedes permettant d'inhiber des maladies proliferatives par inhibition d'angiogenese a mediation tgf-beta
AR020717A1 (es) 1998-10-07 2002-05-22 Syngenta Participations Ag Proteinas terapeuticamente activas en plantas.
US6677432B1 (en) 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
WO2000054797A2 (fr) 1999-03-17 2000-09-21 Novartis Ag Compositions pharmaceutiques
AU3269399A (en) * 1999-03-22 2000-10-09 Universitat Zurich Transforming growth factor (tfg) beta superfamily antagonists
EP1272649A2 (fr) 2000-04-03 2003-01-08 Monsanto Technology LLC Expression et purification de polypeptides authentiques bioactifs issus de plantes
PT1279677E (pt) * 2000-04-25 2007-06-12 Otsuka Pharma Co Ltd Péptidos miméticos de gd 3
US20040078851A1 (en) * 2000-05-02 2004-04-22 Ning Huang Production of human growth factors in monocot seeds
DE10026713A1 (de) 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
WO2002012336A2 (fr) * 2000-08-09 2002-02-14 Curis, Inc. THERAPEUTIQUES DU TGF-β, COMPOSITIONS ET PROCEDES D'UTILISATION
AU2002257703A1 (en) 2001-03-23 2002-10-08 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders
WO2002099067A2 (fr) 2001-06-05 2002-12-12 Oishi Karen K Expression genique et production de proteines tgf-b comprenant une substance inhibitrice mullerienne bioactive issue de vegetaux
CN1685047A (zh) 2002-09-27 2005-10-19 遗传工程与生物技术中心 用于生产转质体基因组被子植物的载体
JP5650367B2 (ja) * 2004-02-27 2015-01-07 アンティセンス ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング 医薬組成物
DE602005022082D1 (de) 2004-08-19 2010-08-12 Biogen Idec Inc Rückfaltung von proteinen der transforming-growth-factor-beta-familie
US20060162026A1 (en) 2004-12-23 2006-07-20 Karen Oishi Expressing TGF-beta proteins in plant plastids
GB0514262D0 (en) * 2005-07-12 2005-08-17 Renovo Ltd Promotion of epithelial regeneration
CA2614754A1 (fr) * 2005-07-12 2007-01-18 Renovo Ltd Compositions pharmaceutiques
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0617816D0 (en) 2006-09-11 2006-10-18 Renovo Ltd Nucleic acids and methods of protein expression

Also Published As

Publication number Publication date
WO2007104946A2 (fr) 2007-09-20
GB0604966D0 (en) 2006-04-19
US7902150B2 (en) 2011-03-08
EP2012812A2 (fr) 2009-01-14
IL193700A0 (en) 2011-08-01
US20090137475A1 (en) 2009-05-28
EP2359844A2 (fr) 2011-08-24
AR062773A1 (es) 2008-12-03
BRPI0708791A2 (pt) 2011-06-14
KR20080100828A (ko) 2008-11-19
RU2008140117A (ru) 2010-04-20
JP2009543757A (ja) 2009-12-10
WO2007104946A3 (fr) 2008-04-24
EP2359844A3 (fr) 2011-09-14
CN101605555A (zh) 2009-12-16
MX2008011707A (es) 2008-09-26

Similar Documents

Publication Publication Date Title
NO20084187L (no) Medikamenter og proteiner
NO20081878L (no) Diacylindazolderivater som lipase- og fosfolipaseinhibitorer
NO20092527L (no) Prolegemidler, fremgangsmate for fremstilling og anvendelse derav
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
NO20065195L (no) Terapeutiske enzymformuleringer og anvendelser derav
DK1543063T3 (da) Medikament levering
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
PL1909843T3 (pl) Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne i ich zastosowanie w dziedzinie farmacji
NO20092254L (no) Pulverformuleringer for valganciclovir
DK1771155T3 (da) Fremgangsmåde og sammensætning til behandling af rhinitis
CY1119580T1 (el) Νεα φαρμακα σκευασματα χρησιμα στη θεραπευτικη αγωγη της αϋπνιας
BR0311700A (pt) Processo para a produção de uma preparação em forma de pelìcula e preparação em forma de pelìcula
JP2010538020A5 (fr)
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
CY1118967T1 (el) Φαρμακευτικες συνθεσεις υψηλης δοσης βιοτινης
NO20080034L (no) Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer
DE502005007472D1 (de) Desoxo-nonadepsipeptide
RS54185B1 (en) USE OF 24-ORDER
BRPI0715361B8 (pt) uso de polietileno glicol em inflamação relacionada com doenças ou distúrbios tópicos e cicatrização de ferimento
AU2002346594A1 (en) Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
NO20044321L (no) Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase
WO2007108004A8 (fr) Derives du s-alkylisothiouronium pour le traitement de maladies inflammatoires
EA200700413A1 (ru) Ариламинкетоны, способ их получения, фармацевтические композиции, содержащие их, и их применение

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application